Boehringer Ingelheim GmbH, the German family-owned drugmaker, agreed to pay $650 million to settle the majority of lawsuits filed over its blood thinner Pradaxa, which has been linked to more than 500 patient deaths.
Boehringer, slated to face the first U.S. trial in September of claims there was no antidote to stop bleed-out deaths among Pradaxa patients, is seeking to resolve about 4,000 suits, company officials said in a statement today. That would provide an average per-case payout of $162,500.
21:27 Judge Gorsuch and the frozen truck driver14
23:03 Trump administration calls the structure of the Consumer Financial Protection Bureau unconstitutional in court filing20
07:19 South Korea court reassigns Samsung chief's case amid questions about judge's connections23
21:57 After Florida prosecutor says she won’t seek death penalty, governor reassigns case of slain police officer29